Los Angeles, Calif. – The AIDS Clinical Trials Group (ACTG), the world’s largest and longest established HIV research network, today announced the initiation of ACTG 5395, a clinical trial to evaluate whether the drug combination hydroxychloroquine and azithromycin can prevent hospitalization and death from COVID-19 (which is caused by infection with the virus SARS-CoV-2). There…
WASHINGTON – The Society for Cardiovascular Angiography and Interventions (SCAI) has released an expert consensus statement describing recommendations for the management of patients with out-of-hospital cardiac arrest (OHCA). The statement, published today in Catheterization and Cardiovascular Interventions, was presented during the SCAI 2020 Scientific Sessions Virtual Conference. OHCA continues to present as significant public health…
A clinical trial has begun to evaluate whether the malaria drug hydroxychloroquine, given together with the antibiotic azithromycin, can prevent hospitalization and death from coronavirus disease 2019 (COVID-19). The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is sponsoring the trial, which is being conducted by the NIAID-funded…
It has been nearly two decades since the American College of Medical Genetics and Genomics (ACMG), together with the American College of Obstetricians and Gynecologists, made the landmark recommendation that cystic fibrosis (CF) become the first target of pan-ethnic universal carrier screening, with ACMG identifying a core panel of 23 pathogenic variants to be tested.…
BIRMINGHAM, Ala. – Many heart diseases are linked to oxidative stress, an overabundance of reactive oxygen species. The body reacts to reduce oxidative stress — where the redox teeter-totter has gone too far up — through production of endogenous antioxidants that reduce the reactive oxygen species. This balancing act is called redox homeostasis. But what…
WASHINGTON – The Society for Cardiovascular Angiography and Interventions (SCAI) today issued a position statement on the performance of percutaneous coronary intervention (PCI) in ambulatory surgical centers (ASCs). The document was published in SCAI’s official journal, Catheterization and Cardiovascular Interventions. Earlier this year, The Centers for Medicare & Medicaid Services (CMS) began reimbursement for PCI…
Scientists from the Walter Reed Army Institute of Research joined partners at Duke University, Florida Atlantic University and Montana State University to publish a study providing clear evidence that malaria’s characteristic cycle of fever and chills is a result of the parasite’s own influence–not factors from the host. What regulated that cycle, the result of…
WASHINGTON – The Society for Cardiovascular Angiography and Interventions (SCAI) has published a position statement addressing optimal percutaneous coronary intervention (PCI) treatment of patients with complex coronary artery disease (CAD). The position statement was presented today during the SCAI 2020 Scientific Sessions Virtual Conference and published in SCAI’s official journal, Catheterization and Cardiovascular Interventions. While…
In a study published today in Current Biology, Arne Meyer, John O’Keefe and Jasper Poort used a lightweight eye-tracking system composed of miniature video cameras and motion sensors to record head and eye movements in mice without restricting movement or behaviour. Measurements were made while the animals performed naturalistic visual behaviours including social interactions with…
WASHINGTON – The Society for Cardiovascular Angiography and Interventions (SCAI) has released guidelines that provide a comprehensive review of comparative effectiveness data for devices used in aorto-iliac arterial interventions. The recommendations aim to provide clinicians with guidance for device selection in patients for whom these devices are intended as definitive therapy. The document was published…